They burned $10M in operations while reporting $110M in net income, then guided 25% growth on a shipment base that shrank.
Thesis: ACM gained share in a flat China WFE market (35% cleaning share) while building a new product cycle, but the earnings-to-cash gap of $120M and declining shipments mean the market has no proof the ramp converts. The structural position is real; the cash flow confirms nothing yet.
Verdict: HOLD — Conviction: MEDIUM
Catalyst: Q1 2026 at 18-20% of full-year revenue with first SPM and furnace shipments converting, plus gross margin returning above 42% as inventory provisions normalize.
Key Risk: Operating cash flow stays negative through 2026 as capex doubles to $200M, forcing further ACM Shanghai or US equity raises while shipment growth fails to materialize above revenue growth.
The Tell: When JPMorgan asked when Taiwan panel-level packaging orders would become visible, CEO deflected: 'we announced that we do have also PO from outside Mainland China... So you know what I mean here.' He refused to commit to timing on the single highest-value product line.
Friction Level: HIGH_FRICTION — Whether the 12% shipment decline into 25% revenue guidance is a pushout timing artifact (bull) or a Say/Do Gap revealing deteriorating demand conversion (bear).
2025Q4 · Feb 26, 2026
3 of 5 readings agreed3 HOLD · 2 SHORTRead the full call
Shipments Down 12%, Guidance Says Up 25%, Cash Flow Says Negative
ACM gained share in a flat China WFE market (35% cleaning share) while building a new product cycle, but the earnings-to-cash gap of $120M and declining shipments mean the market has no proof the ramp converts. The structural position is real; the cash flow confirms nothing yet.
When JPMorgan asked when Taiwan panel-level packaging orders would become visible, CEO deflected: 'we announced that we do have also PO from outside Mainland China... So you know what I mean here.' He refused to commit to timing on the single highest-value product line.
Full-year shipments fell 12.2% to $854M against $901M revenue (book-to-bill 0.95) and Q4 shipments dropped 13.5% YoY, yet management guides 25% revenue growth for 2026. The gap between physical pipeline and revenue recognition is the core unresolved question.
Core cleaning (69% of revenue) grew only 8.1%. Advanced packaging ex-ECP grew 45% off a $53M base = 8% of total. Every new product (SPM, furnace, track, PECVD, panel plating) is pre-revenue or demo-stage. AI narrative runs ahead of actual contribution.
One Taiwan key player stated they only accept horizontal plating. ACM delivered the first horizontal panel-level plating tool and management claims to be the only supplier. SPM nozzle design achieved sub-20 particle count driving repeat orders from a major customer.
Capex jumps from $58M to $200M for Lingang second building, mini line, and Oregon facility in H2 2026. Management is funding expansion from $845M net cash despite negative OCF, committing real capital to the ramp.
CEO stated patents 'lock the technology so global customers have almost no choice but to come to ACM.' Repeat SPM orders driven by proprietary nozzle design. Singapore foundry installation underway with follow-on clean and plating tools expected.
Track and PECVD compete against TEL and Screen with tools still in evaluation stage. KrF track delivered September 2025 for evaluation, mass production qualification only expected 2026. PECVD tools running wafer tests in mini lab, not yet shipped to customers.
+20
NEUTRAL"CFO gave precise linearity (Q1 at 18-20%, H1 42-43%) but CEO deflected quantification questions, telling JPMorgan 'you know what I mean here' instead of timing Taiwan POs, and was asked to repeat a question."
Full transcript with specific financials, segment breakdowns, and customer concentration data. But management gave no dollar quantification on global wins and no explanation for the $120M earnings-to-cash gap.
Q1 2026 at 18-20% of full-year revenue with first SPM and furnace shipments converting, plus gross margin returning above 42% as inventory provisions normalize.
Operating cash flow stays negative through 2026 as capex doubles to $200M, forcing further ACM Shanghai or US equity raises while shipment growth fails to materialize above revenue growth.
“Revenue was $244 million for the fourth quarter, up 9.4%.”
Figures are extracted from the transcripts and checked in code: every quote appears word for word. Descriptive only: none of this feeds the verdict.
15% growth against a flat China WFE market with near-zero new product contribution = structural share gain, not cyclical tailwind. Guidance of 25% growth at midpoint with new products just starting. Shipments expected to grow faster than revenue in 2026, a leading indicator. Raw materials up $23.5M QoQ for supply chain pre-positioning. Singapore foundry, 3 global AP customers, horizontal plating monopoly in a Taiwan segment with no alternative. $845M net cash funds a $200M capex ramp. Gross margin trough at 41% is mix plus provisions, both reversing. Semi-critical pricing pressure is a deliberate retreat from low-margin products crowded by 5+ Chinese entrants.
The $120M gap between $110M net income and -$10M operating cash flow is the headline. The $845M net cash came from a $623M Shanghai equity raise, not operations. Shipments fell 12% while guiding 25% up is a Say/Do Gap that management cannot prove out yet. Gross margin fell 590bp for the year to 44.5%, Q4 hit 41% below target, and operating margin collapsed 970bp to 15.9% with CFO guiding mid-teens for 2026. Core cleaning, 69% of revenue, grew only 8.1%. Semi-critical pricing pressure hit back-to-back quarters and is structural, not one-time. Capex doubling to $200M on negative OCF means more dilution from dual-raise structure.
Say/Do Gap
Shipments fell 12.2% to $854M against $901M revenue (B2B 0.95) while guiding 25% growth. Q4 shipments dropped 13.5% YoY. Revenue grew while the physical pipeline shrank. Management claims 2026 shipments will exceed revenue growth but has not proven it.
Earnings Quality: $120M Cash Gap
Operating cash flow was -$10M for full year 2025 against $110.2M reported net income. The $845M net cash balance was manufactured by a $623M ACM Shanghai equity raise. Capex doubling to $200M on negative OCF means funding comes from dilution.
Margin Compression Structural
Gross margin fell 590bp for the year (50.4% to 44.5%), operating margin fell 970bp (25.6% to 15.9%). Semi-critical pricing pressure from 5+ Chinese entrants hit Q3 and Q4 back-to-back. CFO guides 2026 operating margin at mid-teens, confirming third year of erosion.
AI Label Without Substance
Core cleaning grew only 8.1%. Advanced packaging ex-ECP grew 45% off $53M base = 8% of total revenue. All new products (SPM, furnace, track, PECVD, panel plating) are pre-revenue. Singapore and global wins are unquantified in dollars.
Generation-Skipping Execution Risk
Track and PECVD compete against TEL and Screen with tools in evaluation only. KrF track delivered September 2025 for evaluation, mass production qualification expected 2026. PECVD still running wafer tests in mini lab, not shipped to customers.
HOLD. The structural share gain in China cleaning is real, and horizontal plating gives genuine pricing power in panel packaging. But the $120M earnings-to-cash gap and 12% shipment decline into 25% guidance means I cannot size the position until Q1 2026 shipments and OCF confirm the ramp. Long the stock only if Q1 shipments exceed $200M and operating cash flow turns positive. Short if shipments stay negative two more quarters. Current risk/reward is symmetric, which means no edge.